Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Moringa powder tested to boost breast milk and baby health

NCT ID NCT07605091

Knowledge-focused Sponsor: Philip Kern Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This study looks at whether taking moringa leaf powder daily can help breastfeeding mothers produce more milk and improve the health of both mom and baby. About 100 mothers and their newborns will be randomly assigned to eat porridge with or without moringa for four months. Researchers will track milk output, hormone levels, and infant growth for up to two years.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Moringa leaf powder
What this could lead to
If it works, this could point toward a simple dietary supplement to support breastfeeding mothers and improve infant nutrition.
What could go wrong
This is an early-stage study with only 100 participants, so results may not apply to everyone. It's not designed to prove a cure or treatment for any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2026

An estimate. Start dates often move.

Expected to finish

Jun 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

7 days to 99 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Mothers: Inclusion criteria - \>18 years of age, s/p delivery of a healthy infant, and planning breast feeding. * Infants: must be born at term (=37-42 weeks), singleton birth, lactating, age 7-21 days at enrollment Exclusion Criteria: * Mothers - women reporting regular consumption of moringa in the last month (\>1 time weekly), unable to consume moringa or unable to complete study activities within the first two weeks. * Mothers - Women with a contraindication to Moringa use (blood thinners, levothyroxine, antihypertensive treatments, insulin dependency). * Infants - significant congenital disease, are unable to feed orally.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast feeding are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Breast Feeding lactation disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast feeding Lactation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • SUNDY Downstate

    Brooklyn, New York, 11203, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.